glucaric acid has been researched along with Anemia in 124 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (10.48) | 18.7374 |
1990's | 12 (9.68) | 18.2507 |
2000's | 51 (41.13) | 29.6817 |
2010's | 46 (37.10) | 24.3611 |
2020's | 2 (1.61) | 2.80 |
Authors | Studies |
---|---|
Butragueño-Laiseca, L; de la Mata Navazo, S; Sánchez Galindo, AC; Santiago Lozano, MJ | 1 |
Bai, Z; Feng, R; Guo, X; Hong, C; Qi, X; Romeiro, FG; Xu, X; Zhang, D | 1 |
Frey, M; Kerrey, BT; Overmann, KM; Richert, A | 1 |
Barea-Mendoza, J; Brashears, SL; Cortés-Puch, I; Kim-Shapiro, DB; Klein, HG; Natanson, C; Perlegas, A; Solomon, SB; Suffredini, DA; Sun, J; Xu, W | 1 |
Imai, N; Shibagaki, Y; Taki, Y | 1 |
Alcântara Rodrigues de Moraes, M; Bueno Garcia, E; Francescato Veiga, D; Masako Ferreira, L; Montano-Pedroso, JC | 1 |
Baron, F; Beguin, Y; Bonnet, C; De Prijck, B; Fillet, G; Hafraoui, K; Jaspers, A; Maertens, J; Schots, R; Seidel, L; Servais, S; Vanstraelen, G; Willems, E | 1 |
Forward, DP; Moppett, IK; Rowlands, M; Sahota, O | 1 |
Abbasi, S; Abdel-Razeq, H; Abdelelah, H; Jaber, R; Saadi, I | 1 |
Kalaivani, K | 1 |
Agarwal, N; Bhatla, N; Dash, BB; Kriplani, A; Kulshreshta, V; Mahey, R | 1 |
Athibovonsuk, P; Manchana, T; Sirisabya, N | 1 |
Mekic, M; Musanovic, A; Trnacevic, S | 1 |
Berry, S; Burlew, CC; Cappa, A; Holena, DN; Jaouen, B; Jurkovich, J; Maier, R; Moore, EE; Pieracci, FM; Rodil, M; Stovall, RT | 1 |
Artz, AS; Barnhart, H; Berger, NA; Chelune, G; Cohen, HJ; Ershler, WB; Gordeuk, VR; Prchal, J; Price, E; Rao, SV; Reuben, D; Roy, CN; Sapp, S; Schrier, SL; Supiano, MA; Walston, JD | 1 |
Corwin, HL; Napolitano, LM | 1 |
Albinarrate, A; Barrachina, B; López-Ariznabarreta, C; López-Picado, A; Molano, J; Oiartzabal, I | 1 |
Kox, M; Pickkers, P; van Eijk, LT | 1 |
Pieracci, FM | 1 |
Baron, F; Beguin, Y; Bonnet, C; De Prijck, B; Fillet, G; Hafraoui, K; Jaspers, A; Maertens, J; Schots, R; Servais, S; Willems, É | 1 |
Ang, D; Bavry, AA; Beck, A; Efron, P; Rebel, A | 1 |
Airy, M; Brookhart, MA; Chang, TI; Ding, VY; Goldstein, BA; Mandayam, S; Mitani, AA; Winkelmayer, WC | 1 |
Couffignal, C; Driss, F; Dufour, G; Duval, X; Lasocki, S; Lefebvre, T; Piednoir, P; Puy, H; Rineau, E; Schilte, C | 1 |
Amato, C; Barbieri, C; Bellocchio, F; Bolzoni, E; Canaud, B; Cattinelli, I; Gatti, E; Macdougall, IC; Mari, F; Martin, JD; Stopper, A; Stuard, S | 1 |
Cao, G; Dominici, FP; Giani, JF; Rivas, C; Toblli, JE | 1 |
Ferreira, LM; Garcia, EB; Montano-Pedroso, JC; Novo, NF; Veiga, DF | 1 |
Kozlovskaya, LV; Markina, MM; Milovanov, YS; Milovanova, SY; Mukhin, NA | 1 |
Gemici, C; Mayadagli, A; Ozden, S; Ozyurt, H; Tepetam, H; Yaprak, G; Yetmen, O | 1 |
Bugat, R; Duvillié, L; Espié, M; Luporsi, E; Perot, S; Pithois Merli, I; Scotté, F; Spaeth, D; Toledano, A | 1 |
Airy, M; Brookhart, MA; Chang, TI; Ding, VY; Fishbane, S; Goldstein, BA; Mandayam, S; Mitani, AA; Winkelmayer, WC | 1 |
Cuenca, J; García-Erce, JA; Muñoz, M | 1 |
Auerbach, M; Ballard, H | 1 |
Backe, B; Borthen, I; Kolås, T; Løkvik, B; Nakling, J; Rognerud Jensen, OH; Salvesen, KA; Smedvig, E; Westad, S; Økland, I | 1 |
Arnaout, L; Bellamy, L; Chabbouh, T; Ozier, Y; Rosencher, N | 1 |
Lorch, JA; Pollak, VE; Satwah, S; Shukla, R | 1 |
Befrits, R; Blom, H; Eriksson, A; Grännö, C; Hjortswang, H; Lindgren, A; Lindgren, S; Ung, KA; Unge, P; Wikman, O | 1 |
Chung, HH; Kang, SB; Kim, SC; Kim, YH; Kim, YT | 1 |
Nguyen, TV | 1 |
Bencaiova, G; Breymann, C; Krafft, A | 1 |
Bruguera, J; Cladellas, M; Comín-Colet, J; Rizzo, M; Ruiz, S; Torres, A | 1 |
Cooper, B; Healy, H; Irish, AB; Kark, A; Kent, AB; Kerr, PG; McMahon, LP; Roger, SD | 1 |
Dangsuwan, P; Manchana, T | 1 |
Alonso, E; Canser, E; Gilsanz, F; Gredilla, E; Martínez Serrano, B; Pérez-Ferrer, A | 1 |
Chen, HH; Chen, YC; Chuang, CK; Lee, KF; Lin, HC; Wu, CJ | 1 |
Fernández-Gallego, J; Martín, MA; Sujan, S; Vega, E | 1 |
Hojs, N; Malovrh, M; Premru, V | 1 |
Benítez, PC; Cabello, LM; Chofles, LC; Lázaro, PS; Serrano-Trenas, JA; Ugalde, PF | 1 |
Breymann, C; Krafft, A | 1 |
Kim, S; Lee, SC; Lim, H; Yoon, J | 1 |
Atalay, H; Guney, I; Kaya, E; Solak, Y; Turk, S; Turkmen, K | 1 |
Bisbe, E; Díez-Lobo, AI; García-Erce, JA; Muñoz, M | 1 |
Cordero, J; Muñoz, M; Naveira, E; Seara, J | 1 |
Gollapudi, S; Hassanzadeh, T; Ichii, H; Masuda, Y; Saffarian, M; Vaziri, ND | 1 |
Bosch, MA; Bruguera, J; Cladellas, M; Comín-Colet, J; Farré, N; Gómez, M; Meroño, O; Molera, R; Segovia, A; Vila, J | 1 |
Bradbury, BD; Brookhart, MA; Freburger, JK; Kshirsagar, AV; Ng, LJ | 1 |
Christoph, P; De Tejada, BM; Irion, O; Schuller, C; Studer, H; Surbek, D | 1 |
Chen, J; Chen, X; Cheng, M; Peng, Y; Yang, L; Yin, L | 1 |
Benmaadi, A; Bounhiol, C; Cohen, Y; Couprie, R; Dahan, H; Drahi, G; Griuncelli, M; Janklewicz, P; Loridon, C; Machado, G; Rostoker, G; Roy, M | 1 |
Devasenapathy, N; Neogi, SB; Zodpey, S | 1 |
Baruch, R; Blum, M; Iaina, A; Keren, G; Schwartz, D; Shaked, M; Sheps, D; Silverberg, DS; Steinbruch, S; Tchebiner, J; Wexler, D; Yachnin, T; Zubkov, A | 2 |
Antoni, G; Beshara, S; Danielson, BG; Långström, B; Lubberink, M; Lundqvist, H; Sörensen, J; Tolmachev, V | 1 |
Albarracín, C; Fanlo, B; Junquera, E; Rodríguez Palomares, JR | 1 |
Blum, M; Iaina, A; Keren, G; Schwartz, D; Sheps, D; Silverberg, DS; Wexler, D | 1 |
Cohen, G; Deicher, R; Hörl, WH; Müllner, M; Ziai, F | 1 |
DESHMUKH, PL | 1 |
ASSALI, NS; NICHOLSON, DB | 2 |
HAGEN, A; LARSEN, V; LASSEN, N | 1 |
DEVOE, RW; MOSES, LE | 1 |
GARRISON, FE; HOBSON, JB; ITOGA, T; JONES, OW; LASZLO, J | 1 |
Bugat, R; Mourey, L; Séronie-Vivien, S; Tohfe, M | 1 |
Avram, MM; Blaustein, DA; Chattopadhyay, J; Daoui, R; Gadh, R; Schwenk, MH; Singh, H | 1 |
BENSLEY, EH; CAMERON, DG; GRAYSTON, V; WOOD, P | 1 |
STRAHM, A; WALTER, F | 1 |
HOLLY, RG | 1 |
Blum, M; Iaina, A; Schwartz, D; Silverberg, D; Wexler, D | 1 |
Almer, S; Bodemar, G; Danielson, BG; Kechagias, S | 1 |
Aronoff, GR; Bennett, WM; Blumenthal, S; Charytan, C; Pennell, JP; Reed, J; Rothstein, M; Strom, J; Van Wyck, D; Wolfe, A; Yee, J | 1 |
Blaustein, DA; Schwenk, MH | 1 |
Cuenca Espiérrez, J; García Erce, JA; Martínez Martín, AA; Modrego Aranda, FJ; Solano, VM | 1 |
MEGASSINI, VE; MHANI, NO | 1 |
Cuenca, J; García-Erce, JA; Martínez, AA; Molina, J; Muñoz, M; Solano, VM | 1 |
Erturk, S; Keven, K; Kutlay, S; Nergizoglu, G | 1 |
Durandy, Y; Hulin, S | 1 |
Barut, Y; Eres, M; Gürsu, RU; Murat, B; Ozdemir, A; Selamet, U; Yalinbaş, B | 1 |
Hörl, WH; Sengölge, G; Sunder-Plassmann, G | 1 |
Födinger, M; Hörl, WH; Mittermayer, F; Puttinger, H; Schaller, G; Scheiber-Mojdehkar, B; Sunder-Plassmann, G; Vychytil, A; Wolzt, M | 1 |
Martinez, CO; Mazey, RM; McMurray, S; Roppolo, M; Van Wyck, DB | 1 |
Ghannam, M; Karkouti, K; McCluskey, SA; Quirt, I; Salpeter, MJ; Yau, TM | 1 |
Anbu, AT; Bradbury, MG; Kemp, T; O'donnell, K; Smith, PA | 1 |
Cuenca, J; García-Erce, JA; Muñoz, M; Naveira, E; Palmer, JH; Seara, J | 1 |
Canser, E; Gilsanz, F; Gimeno, M; Gredilla, E; Martínez, B; Pérez Ferrer, A | 1 |
Clark, AL; Cleland, JG; Coletta, AP; Loh, PH; Tin, L | 1 |
Bartlett, FR; Bolger, AP; Chapman, CM; Kaprielian, R; O'Leary, J; Penston, HS; Pollock, N | 1 |
Cardona, R; Cuenca, J; García-Erce, JA; Martínez, F; Muñoz, M; Pérez-Serrano, L | 1 |
Gershanovich, ML; Livshits, ME; Makhnova, EV | 1 |
Cho, HJ; Kim, JH; Kim, JW; Kim, SH; Kim, SW; Kim, YT; Nahm, EJ; Yoon, BS | 1 |
Cuenca Espiérrez, J; García-Erce, JA; Gómez Barrera, M; Izuel Rami, M; Rabanaque Hernández, MJ; Villar Fernández, I | 1 |
Camps, J; Ferré, N; Joven, J; Mackness, B; Mackness, M; Marcas, L; Marsillach, J; Martínez-Vea, A | 1 |
Deveci, M; Oymak, O; Sari, I; Sav, T; Sipahioglu, MH; Tokgoz, B; Utas, C | 1 |
Auerbach, M; Rodgers, GM | 1 |
Martinez, A; Thomas, J | 1 |
SLACK, HG; WILKINSON, JF | 1 |
Li, H; Wang, SX | 1 |
Fujita, I; Hara, K; Hirota, M; Ito, N; Nagasawa, M; Nakatomi, M; Nasu, M; Saito, A; Shigeno, Y; Tanaka, H; Yamaguchi, K | 1 |
Fukaya, S; Imamura, T; Iwamoto, T; Kanou, H; Konjiki, O; Takasaki, M | 1 |
Irimajiri, S; Matsuoka, Y; Ohoike, H; Suzuki, A | 1 |
Fehr, J; Höchli, P; Wagenhäuser, FJ | 1 |
Blum, M; Frank, N; Iaina, A; Kaplan, E; Levi, BA; Peer, G; Silverberg, DS; Steinbruch, S | 1 |
Mercuriali, F | 1 |
Tryba, M | 1 |
Blum, M; Iaina, A; Kaplan, E; Peer, G; Silverberg, DS | 1 |
Cazzola, M | 1 |
Akcicek, F; Atabay, G; Basci, A; Celik, A; Cirit, M; Ok, E; Ozkahya, M; Toz, H; Unsal, A | 1 |
Bernière, J; Dehullu, JP; Gall, O; Murat, I | 1 |
Antoni, G; Beshara, S; Danielson, BG; Långström, B; Lubberink, M; Lundqvist, H; Sundin, J; Tolmachev, V; Valind, S | 1 |
Chang, HY; Chen, KS; Kao, HH; Lee, CC; Tsai, CJ | 1 |
Agbaria, Z; Baruch, R; Blum, M; Deutsch, V; Iaina, A; Irony, M; Schwartz, D; Silverberg, DS; Steinbruch, S; Yachnin, T | 1 |
Gottschalk, R; Kaltwasser, JP; Kessler, U; Möller, B; Stucki, G | 1 |
Gosriwatana, I; Hider, RC; Kersting, S; Kooistra, MP; Lu, S; Marx, JJ; Nijhoff-Schutte, J | 1 |
Eran, A; Harmankaya, O | 1 |
Glassman, E | 1 |
Casciani, CU; Di Nucci, G; Elia, L; Mandelli, F; Mariani, G; Meloni, C; Piazza, A; Taccone-Gallucci, M; Torromeo, C; Valeri, M | 1 |
5 review(s) available for glucaric acid and Anemia
Article | Year |
---|---|
Intravenous iron in oncology.
Topics: Anemia; Antineoplastic Agents; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Injections, Intravenous; Iron-Dextran Complex; Neoplasms | 2008 |
[Blood conservation approaches in orthopedic surgery].
Topics: Anemia; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Blood Transfusion, Autologous; Drug Administration Schedule; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemodilution; Humans; Intraoperative Complications; Orthopedic Procedures; Postoperative Hemorrhage; Preoperative Care; Recombinant Proteins; Sucrose; Time Factors; Tranexamic Acid; Transfusion Reaction | 2008 |
Is intravenous iron sucrose the treatment of choice for pregnant anemic women?
Topics: Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Treatment Outcome | 2013 |
Intravenous iron therapy: well-tolerated, yet not harmless.
Topics: Anemia; Cytokines; Endothelial Cells; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gluconates; Hematinics; Humans; Injections, Intravenous; Iron; Iron-Dextran Complex; Kidney Failure, Chronic; Neutrophils | 2005 |
Epoetin alfa for autologous blood donation in patients with rheumatoid arthritis and concomitant anemia.
Topics: Anemia; Arthritis, Rheumatoid; Blood Transfusion; Blood Transfusion, Autologous; Dose-Response Relationship, Drug; Double-Blind Method; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Humans; Injections, Intravenous; Injections, Subcutaneous; Orthopedics; Premedication; Recombinant Proteins; Treatment Outcome | 1996 |
45 trial(s) available for glucaric acid and Anemia
Article | Year |
---|---|
Intravenous iron sucrose versus oral iron administration for the postoperative treatment of post-bariatric abdominoplasty anaemia: an open-label, randomised, superiority trial in Brazil.
Topics: Abdominoplasty; Administration, Intravenous; Administration, Oral; Adult; Anemia; Bariatric Surgery; Biomarkers; Brazil; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Middle Aged; Risk Factors; Treatment Outcome; Young Adult | 2018 |
Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: a prospective multicenter randomized trial.
Topics: Aged; Anemia; Blood Transfusion; Combined Modality Therapy; Darbepoetin alfa; Drug Therapy, Combination; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Injections, Subcutaneous; Lymphoma; Male; Middle Aged; Multiple Myeloma; Postoperative Complications; Quality of Life; Transferrin; Transplantation Conditioning; Transplantation, Autologous | 2013 |
The effect of intravenous iron on postoperative transfusion requirements in hip fracture patients: study protocol for a randomized controlled trial.
Topics: Aged; Anemia; Biomarkers; Clinical Protocols; Drug Administration Schedule; England; Erythrocyte Transfusion; Ferric Compounds; Ferric Oxide, Saccharated; Fracture Fixation; Glucaric Acid; Hematinics; Hemoglobins; Hip Fractures; Hospitals, University; Humans; Infusions, Intravenous; Pilot Projects; Postoperative Hemorrhage; Research Design; Reticulocyte Count; Time Factors; Treatment Outcome | 2013 |
Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy.
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Genital Neoplasms, Female; Glucaric Acid; Hematinics; Hemoglobins; Humans; Middle Aged; Paclitaxel | 2013 |
A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness*.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anemia; APACHE; Critical Illness; Erythrocyte Transfusion; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Intensive Care Units; Male; Middle Aged; Protoporphyrins; Single-Blind Method; Transferrin; Trauma Centers; Young Adult | 2014 |
A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/mL.
Topics: Aged; Aged, 80 and over; Anemia; Cognition; Drug Administration Schedule; Exercise Test; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Injections, Intravenous; Male; Psychological Tests; Quality of Life; Walking | 2014 |
Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation.
Topics: Anemia; Darbepoetin alfa; Drug Therapy, Combination; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hematinics; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Sucrose; Survival Analysis; Transplantation, Autologous | 2015 |
Postoperative intravenously administered iron sucrose versus postoperative orally administered iron to treat post-bariatric abdominoplasty anaemia (ISAPA): the study protocol for a randomised controlled trial.
Topics: Abdominoplasty; Administration, Intravenous; Administration, Oral; Adolescent; Adult; Anemia; Bariatric Surgery; Biomarkers; Brazil; Clinical Protocols; Drug Administration Schedule; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hematopoiesis; Hemoglobins; Humans; Middle Aged; Quality of Life; Research Design; Surveys and Questionnaires; Time Factors; Treatment Outcome; Young Adult | 2016 |
A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia.
Topics: Administration, Oral; Adolescent; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Middle Aged; Postpartum Period; Prospective Studies; Quality of Life; Sucrose | 2008 |
Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study.
Topics: Administration, Oral; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Inflammatory Bowel Diseases; Injections, Intravenous; Male; Sweden; Treatment Outcome | 2009 |
Safety and usefulness of intravenous iron sucrose in the management of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective, randomized study.
Topics: Administration, Oral; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Menorrhagia; Middle Aged; Preoperative Care; Prospective Studies | 2009 |
Selective use of recombinant human erythropoietin in pregnant patients with severe anemia or nonresponsive to iron sucrose alone.
Topics: Adult; Anemia; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Pregnancy; Recombinant Proteins; Treatment Outcome | 2009 |
Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial.
Topics: Administration, Oral; Aged; Anemia; Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Iron; Kidney Diseases; Male; Middle Aged; Renal Dialysis; Severity of Illness Index | 2010 |
Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Endometrial Neoplasms; Erythrocyte Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Middle Aged; Neoplasms, Multiple Primary; Ovarian Neoplasms; Paclitaxel; Taxoids; Young Adult | 2010 |
Comparison of parenteral iron sucrose and ferric chloride during erythropoietin therapy of haemodialysis patients.
Topics: Anemia; Chlorides; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Parenteral; Male; Middle Aged; Prospective Studies; Renal Dialysis | 2010 |
Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial.
Topics: Aged; Aged, 80 and over; Anemia; Blood Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hip Fractures; Humans; Infusions, Intraventricular; Male; Perioperative Period; Postoperative Complications | 2011 |
Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study.
Topics: Anemia; Anemia, Iron-Deficiency; C-Reactive Protein; Drug Administration Schedule; Drug Therapy, Combination; Erythrocyte Indices; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Interleukin-6; Pregnancy; Pregnancy Complications; Prospective Studies; Recombinant Proteins; Treatment Outcome | 2011 |
Effects of postoperative intravenous iron on transfusion requirements after lower limb arthroplasty.
Topics: Aged; Aged, 80 and over; Anemia; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Transfusion; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Male; Middle Aged; Postoperative Care | 2012 |
[Multi-frequency low-dose intravenous iron on oxidative stress in maintenance hemodialysis patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Renal Dialysis; Sucrose; Young Adult | 2012 |
Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: a MRI study.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Biomarkers; Cross-Sectional Studies; Drug Therapy, Combination; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemosiderosis; Humans; Infusions, Intravenous; Iron; Kidney Failure, Chronic; Liver; Logistic Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Renal Dialysis | 2012 |
Effect of correction of anemia with erythropoietin and intravenous iron in resistant heart failure in octogenarians.
Topics: Age Factors; Aged; Aged, 80 and over; Anemia; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glomerular Filtration Rate; Glucaric Acid; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Renal Insufficiency; Severity of Illness Index; Time Factors | 2003 |
High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity.
Topics: Anemia; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Neutrophils; Peritoneal Dialysis; Phagocytosis; Prospective Studies; Respiratory Burst | 2003 |
The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease.
Topics: Aged; Anemia; Blood Pressure; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Transferrin; Treatment Outcome | 2003 |
Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Drug Hypersensitivity; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Sepsis | 2004 |
[Post-haemodilution anaemia in paediatric cardiac surgery: benefit of intravenous iron therapy].
Topics: Anemia; Cardiac Surgical Procedures; Child; Child, Preschool; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemodilution; Hemoglobins; Humans; Infant; Infusions, Intravenous; Male; Postoperative Complications; Reticulocyte Count; Sucrose | 2005 |
Intravenous iron increases labile serum iron but does not impair forearm blood flow reactivity in dialysis patients.
Topics: Adult; Aged; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Forearm; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Oxidative Stress; Peritoneal Dialysis; Prospective Studies; Regional Blood Flow; Vasodilation | 2005 |
A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD.
Topics: Administration, Oral; Aged; Anemia; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Iron; Male; Middle Aged; Patient Compliance; Quality of Life; Renal Insufficiency, Chronic; Treatment Outcome | 2005 |
Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia.
Topics: Analysis of Variance; Anemia; Cardiac Surgical Procedures; Double-Blind Method; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Male; Middle Aged; Orthopedic Procedures; Postoperative Care; Recombinant Proteins; Time Factors; Treatment Outcome | 2006 |
Role of parenteral iron in transfusion requirements after total hip replacement. A pilot study.
Topics: Aged; Aged, 80 and over; Anemia; Arthroplasty, Replacement, Hip; Blood Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Parenteral; Male; Pilot Projects; Retrospective Studies | 2006 |
[Postpartum and early postoperative anemia after gynecological surgery: treatment with intravenous iron].
Topics: Adolescent; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gynecologic Surgical Procedures; Humans; Injections, Intravenous; Prospective Studies; Puerperal Disorders; Sucrose | 2006 |
Intravenous iron alone for the treatment of anemia in patients with chronic heart failure.
Topics: Aged; Anemia; Cardiac Output, Low; Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Gastrointestinal Diseases; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Iron; Male; Middle Aged; Physical Endurance; Prospective Studies; Transferrin; Walking | 2006 |
Perioperative intravenous iron preserves iron stores and may hasten the recovery from post-operative anaemia after knee replacement surgery.
Topics: Aged; Anemia; Arthroplasty, Replacement, Knee; Blood Component Transfusion; Blood Loss, Surgical; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Male; Perioperative Care; Postoperative Hemorrhage; Receptors, Transferrin; Recombinant Proteins; Reticulocyte Count; Treatment Outcome | 2006 |
Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy.
Topics: Adult; Aged; Anemia; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Middle Aged; Prospective Studies; Uterine Cervical Neoplasms | 2007 |
Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
Topics: Aged; Anemia; Antibodies; Aryldialkylphosphatase; Dose-Response Relationship, Drug; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Injections, Subcutaneous; Kidney Failure, Chronic; Lipid Peroxidation; Lipoproteins, LDL; Male; Middle Aged; Oxidative Stress; Recombinant Proteins; Renal Dialysis; Treatment Outcome | 2007 |
Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran?
Topics: Adult; Aged; Aged, 80 and over; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intra-Arterial; Iron-Dextran Complex; Kidney Failure, Chronic; Male; Middle Aged | 2007 |
Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Topics: Adult; Aged; Anemia; China; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hemoglobins; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Renal Dialysis; Treatment Outcome | 2008 |
Epoetin alfa for autologous blood donation in patients with rheumatoid arthritis and concomitant anemia.
Topics: Anemia; Arthritis, Rheumatoid; Blood Transfusion; Blood Transfusion, Autologous; Dose-Response Relationship, Drug; Double-Blind Method; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Humans; Injections, Intravenous; Injections, Subcutaneous; Orthopedics; Premedication; Recombinant Proteins; Treatment Outcome | 1996 |
Epoetin alfa plus autologous blood donation in patients with a low hematocrit scheduled to undergo orthopedic surgery.
Topics: Anemia; Blood Transfusion; Blood Transfusion, Autologous; Epoetin Alfa; Erythropoiesis; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Humans; Male; Orthopedics; Premedication; Recombinant Proteins; Reticulocyte Count; Sex Characteristics; Treatment Outcome | 1996 |
Intravenous ferric saccharate as an iron supplement in dialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Drug Combinations; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Injections, Intravenous; Iron; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Prospective Studies; Renal Dialysis | 1996 |
The efficiency of fractionated parenteral iron treatment in CAPD patients.
Topics: Adult; Anemia; Drug Administration Schedule; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematocrit; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Organization and Administration; Peritoneal Dialysis, Continuous Ambulatory; Recombinant Proteins; Sucrose; Transferrin | 1997 |
Clinical characteristic of parenteral iron supplementation in hemodialysis patients receiving erythropoietin therapy.
Topics: Anemia; Drug Administration Schedule; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematocrit; Humans; Infusions, Intravenous; Injections, Intravenous; Iron Deficiencies; Middle Aged; Recombinant Proteins; Renal Dialysis; Uremia | 2000 |
The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematocrit; Humans; Infusions, Intravenous; Injections, Subcutaneous; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Renal Dialysis; Sucrose | 2001 |
Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis.
Topics: Adult; Aged; Anemia; Arthritis, Rheumatoid; Disability Evaluation; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Health Status; Humans; Injections, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Quality of Life; Recombinant Proteins; Severity of Illness Index; Treatment Outcome | 2001 |
Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion.
Topics: Anemia; Dialysis Solutions; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Kidney Failure, Chronic; Male; Protein Binding; Renal Dialysis; Transferrin | 2002 |
Low-dose intravenous iron administration in chronic hemodialysis patients treated with recombinant human erythropoietin.
Topics: Aged; Anemia; Dose-Response Relationship, Drug; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Renal Dialysis | 2002 |
75 other study(ies) available for glucaric acid and Anemia
Article | Year |
---|---|
Intravenous iron for critically ill children. Comparison of three dose regimens.
Topics: Anemia; Anemia, Iron-Deficiency; Child; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Iron; Prospective Studies | 2024 |
Use of iron sucrose injection in anemia patients with reduced serum iron concentration during hospitalizations of digestive and liver diseases.
Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hospitalization; Humans; Iron; Liver Diseases | 2021 |
A Toddler With Severe Anemia, Pica, and Extremity Swelling.
Topics: Anemia; Blood Transfusion; Edema; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Foot; Glucaric Acid; Hematinics; Humans; Infant; Male; Oxygen Inhalation Therapy; Pica | 2017 |
Parenteral irons versus transfused red blood cells for treatment of anemia during canine experimental bacterial pneumonia.
Topics: Anemia; Animals; Disease Models, Animal; Dogs; Erythrocyte Transfusion; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Iron; Lung Injury; Mortality; Pneumonia, Bacterial; Pneumonia, Staphylococcal | 2017 |
Zinc deficiency anaemia in haemodialysis patients: Often overlooked but a treatable cause of anaemia.
Topics: Aged, 80 and over; Anemia; Biomarkers; Carnosine; Darbepoetin alfa; Deficiency Diseases; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemoglobins; Humans; Kidney Failure, Chronic; Organometallic Compounds; Renal Dialysis; Treatment Outcome; Zinc; Zinc Compounds | 2017 |
Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study.
Topics: Adult; Aged; Anemia; Antineoplastic Agents; Blood Transfusion; Feasibility Studies; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Pilot Projects; Prospective Studies; Quality of Life; Treatment Outcome | 2013 |
Use of intravenous iron sucrose for treatment of anaemia in pregnancy.
Topics: Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Pregnancy; Pregnancy Complications, Hematologic | 2013 |
Intravenous iron sucrose therapy for moderate to severe anaemia in pregnancy.
Topics: Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Pregnancy; Pregnancy Complications, Hematologic; Prospective Studies | 2013 |
The influence of inflammatory markers and CRP predictive value in relation to the target hemoglobin level in patients on chronic hemodialysis.
Topics: Aged; Anemia; Biomarkers; C-Reactive Protein; Case-Control Studies; Cross-Sectional Studies; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Fibrinogen; Glucaric Acid; Hemoglobins; Humans; Inflammation; Kidney Failure, Chronic; Male; Middle Aged; Predictive Value of Tests; Renal Dialysis; ROC Curve; Sucrose | 2013 |
Anemia in the critically ill: do we need to live with it?*.
Topics: Anemia; Critical Illness; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Intensive Care Units; Male | 2014 |
Assessment of the introduction of a blood management program in orthopaedic surgery.
Topics: Aged; Anemia; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biomarkers; Blood Banks; Blood Loss, Surgical; Blood Transfusion; Blood Transfusion, Autologous; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Hospitals, University; Humans; Length of Stay; Male; Middle Aged; Operative Blood Salvage; Orthopedics; Postoperative Hemorrhage; Program Evaluation; Retrospective Studies; Spain; Tranexamic Acid | 2015 |
Hepcidin as a target of therapy in the treatment of anemia after trauma.
Topics: Anemia; Critical Illness; Female; Ferric Compounds; Glucaric Acid; Hematinics; Humans; Intensive Care Units; Male | 2015 |
The author replies.
Topics: Anemia; Critical Illness; Female; Ferric Compounds; Glucaric Acid; Hematinics; Humans; Intensive Care Units; Male | 2015 |
Successful Rescue Therapy for Severe Acute Anemia: Managing the Critically Ill Jehovah's Witness.
Topics: Aged; Anemia; Aortic Aneurysm, Abdominal; Blood Loss, Surgical; Critical Illness; Epoetin Alfa; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Iron Compounds; Jehovah's Witnesses; Male; Recombinant Proteins; Salvage Therapy | 2015 |
Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients.
Topics: Administration, Intravenous; Aged; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Glucaric Acid; Hematinics; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Prognosis; Proportional Hazards Models; Renal Dialysis; Renal Insufficiency, Chronic; Stroke; United States | 2015 |
Does IV Iron Induce Plasma Oxidative Stress in Critically Ill Patients? A Comparison With Healthy Volunteers.
Topics: Adult; Aged; Anemia; Antioxidants; Area Under Curve; C-Reactive Protein; Case-Control Studies; Critical Illness; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Healthy Volunteers; Humans; Infusions, Intravenous; Interleukin-6; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress | 2016 |
Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients.
Topics: Aged; Anemia; Darbepoetin alfa; Disease Management; Erythropoiesis; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Models, Statistical; Neural Networks, Computer; Renal Dialysis; Retrospective Studies | 2016 |
Intravenous iron sucrose reverses anemia-induced cardiac remodeling, prevents myocardial fibrosis, and improves cardiac function by attenuating oxidative/nitrosative stress and inflammation.
Topics: Anemia; Animals; Cardiotonic Agents; Ferric Compounds; Ferric Oxide, Saccharated; Fibrosis; Glucaric Acid; Inflammation; Infusions, Intravenous; Male; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley; Tyrosine; Ventricular Remodeling | 2016 |
[Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B-4 chronic kidney disease: A new direction of cardionephroprotection].
Topics: Adult; Anemia; Biomarkers; Disease Progression; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Glucuronidase; Hematinics; Hemoglobins; Humans; Iron; Klotho Proteins; Male; Middle Aged; Outcome Assessment, Health Care; Renal Dialysis; Renal Insufficiency, Chronic; Severity of Illness Index | 2016 |
Is there any role of intravenous iron for the treatment of anemia in cancer?
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Agents; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome | 2016 |
Use of iron sucrose and red blood cell transfusions in anaemic cancer patients in France (OncoFer study).
Topics: Adult; Aged; Anemia; Erythrocyte Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; France; Glucaric Acid; Hematologic Neoplasms; Hemoglobins; Humans; Male; Maltose; Middle Aged; Neoplasms; Retrospective Studies | 2017 |
Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex.
Topics: Administration, Intravenous; Aged; Anemia; Cardiovascular Diseases; Cause of Death; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infections; Kidney Failure, Chronic; Male; Middle Aged; Mortality; Proportional Hazards Models; Renal Dialysis; Retrospective Studies | 2017 |
Efficacy of intravenous iron sucrose administration for correcting preoperative anemia in patients scheduled for major orthopedic surgery.
Topics: Anemia; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Orthopedic Procedures; Preoperative Care | 2008 |
The importance of iron in long-term survival of maintenance hemodialysis patients treated with epoetin-alfa and intravenous iron: analysis of 9.5 years of prospectively collected data.
Topics: Adult; Aged; Anemia; Comorbidity; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Infusions, Intravenous; Iron-Dextran Complex; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Recombinant Proteins; Renal Dialysis; Retrospective Studies; Survival Analysis; Transferrin | 2009 |
Comparison of serum ferritin and transferrin saturation values associated with two i.v. iron formulations in hemodialysis patients.
Topics: Adult; Anemia; Cohort Studies; Darbepoetin alfa; Drug Therapy, Combination; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Humans; Injections, Intravenous; Renal Dialysis; Retrospective Studies; Transferrin | 2009 |
A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical ou
Topics: Aged; Aged, 80 and over; Anemia; Chronic Disease; Cohort Studies; Drug Evaluation; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Heart Failure; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Neurotransmitter Agents; Pilot Projects; Prospective Studies; Recombinant Proteins; Survival Rate; Syndrome; Time Factors; Treatment Outcome | 2009 |
[Treating severe acute anemia due to vaginal bleeding in the Jehovah's Witness: a report of 2 cases].
Topics: Adult; Anemia; Anti-Anxiety Agents; Anticoagulants; Cervix Uteri; Combined Modality Therapy; Contraceptives, Oral, Hormonal; Dalteparin; Embolization, Therapeutic; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Immobilization; Jehovah's Witnesses; Menorrhagia; Oxygen Inhalation Therapy; Parenteral Nutrition; Postpartum Hemorrhage; Pregnancy; Recombinant Proteins; Thromboembolism; Treatment Refusal; Young Adult | 2009 |
[Treatment with intravenous iron and ferritin level].
Topics: Anemia; Blood Proteins; Case-Control Studies; Clinical Protocols; Drug Monitoring; Erythropoiesis; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Oxidation-Reduction; Prospective Studies; Renal Dialysis | 2010 |
The influence of need-based, continuous, low-dose iron replacement on hemoglobin levels in hemodialysis patients treated with erythropoiesis-stimulating agents.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 2011 |
Postoperative high-dose intravenous iron sucrose with low dose erythropoietin therapy after total hip replacement.
Topics: Aged; Aged, 80 and over; Anemia; Arthroplasty, Replacement, Hip; Blood Transfusion; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans | 2010 |
Comparison of adverse-event profiles of intravenous low-molecular-weight iron dextran and iron sucrose in peritoneal dialysis patients.
Topics: Adult; Aged; Anemia; Dextrans; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis | 2011 |
A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Costs and Cost Analysis; Elective Surgical Procedures; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Male; Maltose; Middle Aged; Preoperative Care | 2011 |
Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes.
Topics: Adult; Anemia; Apoptosis; Carbohydrates; Escherichia coli; Female; Ferric Compounds; Ferric Oxide, Saccharated; Flow Cytometry; Glucaric Acid; Hematinics; Humans; Kidney Failure, Chronic; Male; Neutrophils; Phagocytosis; Staphylococcus aureus; Time Factors | 2012 |
Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement.
Topics: Aged; Anemia; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Hematinics; Hospital Mortality; Humans; Infusions, Intravenous; Male; Postoperative Period; Preoperative Care; Prospective Studies; Recombinant Proteins; Risk Factors; Spain; Sucrose; Survival Rate; Treatment Outcome | 2012 |
Changing patterns of anemia management in US hemodialysis patients.
Topics: Adolescent; Adult; Aged; Anemia; Child; Child, Preschool; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Iron Compounds; Kidney Failure, Chronic; Male; Middle Aged; Practice Patterns, Physicians'; Renal Dialysis; Time Factors; United States | 2012 |
Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose.
Topics: Administration, Intravenous; Adolescent; Adult; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Maltose; Middle Aged; Pregnancy; Pregnancy Complications, Hematologic; Retrospective Studies; Young Adult | 2012 |
The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization.
Topics: Aged; Anemia; Disease Progression; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Hospitalization; Humans; Injections, Intravenous; Injections, Subcutaneous; Kidney Failure, Chronic; Male; Oxygen Consumption; Recombinant Proteins; Stroke Volume | 2002 |
Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography.
Topics: Adult; Aged; Anemia; Erythrocytes; Female; Ferric Compounds; Ferric Oxide, Saccharated; Follow-Up Studies; Glucaric Acid; Hemoglobins; Humans; Iron Radioisotopes; Liver; Male; Middle Aged; Reticulocyte Count; Spleen; Tomography, Emission-Computed | 2003 |
[Changes in iron metabolism and erythropoietin requirements after the switch from ferric gluconate to iron saccharose. Is it worth the increased expense?].
Topics: Aged; Aged, 80 and over; Anemia; Cost-Benefit Analysis; Drug Costs; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Spain; Sucrose | 2003 |
Intravenous iron therapy with saccharated iron oxide.
Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Iron Compounds | 1952 |
[Hematological response of pregnant to saccharated iron oxide].
Topics: Anemia; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron Compounds; Pregnancy; Pregnancy Complications | 1952 |
[Hemoglobin level in normal pregnancy after injection of colloidal iron saccharate].
Topics: Anemia; Anemia, Hypochromic; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Iron; Pregnancy | 1954 |
Iron therapy in pregnancy; a comparative study of various modes.
Topics: Anemia; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Hematocrit; Hemoglobins; Humans; Iron; Pregnancy; Pregnancy Complications | 1954 |
Infusion of saccharated iron oxide in the treatment of iron deficiency anemia.
Topics: Anemia; Anemia, Hypochromic; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; North Carolina | 1962 |
Epoetin alfa and intravenous iron sucrose to treat severe anemia in a patient with chronic radiation enteropathy: a case report.
Topics: Anemia; Chronic Disease; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hematinics; Hemoglobins; Humans; Infusions, Intravenous; Middle Aged; Radiation Injuries; Recombinant Proteins; Reticulocyte Count | 2003 |
Treatment of iron deficiency anaemia with saccharated iron oxide given by the intravenous route.
Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron | 1951 |
[Intravenous ferric saccharate therapy of iron deficiency anemia in gynecology].
Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gynecology; Humans; Iron | 1951 |
Intravenous iron: evaluation of the use of saccharated iron oxide in iron deficiency states in obstetrics and gynecology.
Topics: Anemia; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Gynecology; Humans; Iron; Obstetrics; Pregnancy | 1951 |
The hematologic response of the pregnant woman to intravenous saccharated iron oxide.
Topics: Anemia; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Iron Compounds; Pregnancy | 1952 |
The use of androgens in anaemia resistant to erythropoietin and i.v. iron in patients with heart and renal failure.
Topics: Aged; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Nandrolone; Nandrolone Decanoate; Sucrose | 2004 |
Treatment of anaemia in inflammatory bowel disease with iron sucrose.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Colitis, Ulcerative; Crohn Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Male; Middle Aged; Retreatment; Retrospective Studies; Sucrose; Treatment Outcome | 2004 |
Rapid, high-dose intravenous iron sucrose therapy in 2 Jehovah's Witness patients with severe anemia, iron deficiency and chronic kidney disease.
Topics: Aged; Anemia; Chronic Disease; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron Deficiencies; Jehovah's Witnesses; Kidney Diseases; Middle Aged; Severity of Illness Index; Time Factors | 2004 |
[Safety and usefulness of parenteral iron in the management of anemia due to hip fracture in the elderly].
Topics: Aged; Aged, 80 and over; Anemia; Blood Loss, Surgical; Blood Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hip Fractures; Humans; Infusions, Intravenous; Iron; Male; Sucrose | 2004 |
[Cooley's syndrome in the adult: treatment with intravenous iron saccharate].
Topics: Adult; Anemia; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron | 1950 |
Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data.
Topics: Aged; Aged, 80 and over; Anemia; Arthroplasty, Replacement, Hip; Blood Transfusion; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hip Fractures; Humans; Infusions, Intravenous; Male; Postoperative Complications; Prospective Studies | 2005 |
Combination of intravenous iron sucrose and ascorbic acid in hemodialysis patients.
Topics: Anemia; Antioxidants; Ascorbic Acid; Drug Therapy, Combination; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Renal Dialysis | 2005 |
Relationship between iron replacement and hepatic functions in hepatitis C virus-positive chronic haemodialysis patients.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hepatic Insufficiency; Hepatitis C, Chronic; Humans; Injections, Intravenous; Kidney Failure, Chronic; Liver; Male; Middle Aged; Renal Dialysis; Retrospective Studies | 2005 |
Low incidence of adverse events following 90-minute and 3-minute infusions of intravenous iron sucrose in children on erythropoietin.
Topics: Anemia; Child; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Prospective Studies; Recombinant Proteins | 2005 |
Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902.
Topics: Anemia; Atorvastatin; Cardiology; Clinical Trials as Topic; Congresses as Topic; Darbepoetin alfa; Diuretics; Erythropoietin; Europe; Exercise Tolerance; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Societies, Medical; Xanthines | 2006 |
[Use of Venofer in management of anemia in cancer patients].
Topics: Adult; Aged; Anemia; Disease Progression; Drug Administration Schedule; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hemoglobins; Humans; Male; Middle Aged; Neoplasms; Quality of Life; Sucrose; Time Factors; Treatment Outcome | 2006 |
[Budget impact analysis of a blood saving program for urgent traumatological surgery].
Topics: Administration, Oral; Age Factors; Aged, 80 and over; Anemia; Budgets; Confidence Intervals; Cost-Benefit Analysis; Costs and Cost Analysis; Data Interpretation, Statistical; Epoetin Alfa; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hip Fractures; Humans; Iron; Length of Stay; Male; Recombinant Proteins | 2007 |
Intravenous iron.
Topics: Anemia; Drug Approval; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Infusions, Intravenous; Iron; Iron-Dextran Complex; Molecular Weight; Renal Dialysis; United States; United States Food and Drug Administration | 2007 |
Blood conservation in the critically ill.
Topics: Adult; Aged; Anemia; Baltimore; Blood; Blood Chemical Analysis; Clinical Protocols; Critical Care; Critical Illness; Drug Costs; Drug Monitoring; Epoetin Alfa; Erythrocyte Transfusion; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematinics; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Outcome and Process Assessment, Health Care; Pilot Projects; Recombinant Proteins | 2007 |
Intravenous treatment of anaemia with an iron-sucrose preparation.
Topics: Anemia; Anemia, Sickle Cell; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iron; Sucrose | 1949 |
[A growth media of genus Legionella in containing saccharated ferric oxide (Fesin) replacing soluble ferric pyrophosphate (author's transl)].
Topics: Anemia; Culture Media; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Iron; Legionella | 1982 |
[A case of hypophosphatemia induced by intravenous administration of saccharated iron oxide].
Topics: Aged; Aged, 80 and over; Anemia; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Hypophosphatemia; Injections, Intravenous | 1994 |
Iatrogenic osteomalacia caused by intravenous administration of saccharated ferric oxide.
Topics: Adult; Anemia; Duodenal Ulcer; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Iatrogenic Disease; Malabsorption Syndromes; Middle Aged; Osteomalacia | 1993 |
Repeated continuous administration of low doses of intravenous iron in anemic patients with active rheumatoid arthritis.
Topics: Anemia; Arthritis, Rheumatoid; C-Reactive Protein; Drug Administration Schedule; Erythrocyte Count; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemoglobins; Humans; Injections, Intravenous; Iron; Time Factors | 1993 |
Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis.
Topics: Administration, Oral; Adult; Aged; Anemia; Anemia, Iron-Deficiency; Delayed-Action Preparations; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Follow-Up Studies; Glucaric Acid; Humans; Injections, Intravenous; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Time Factors | 1996 |
Recombinant human erythropoietin to assist autologous blood donation by patients with anemia.
Topics: Anemia; Arthritis, Rheumatoid; Blood Donors; Blood Transfusion, Autologous; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Hematocrit; Humans; Recombinant Proteins | 1997 |
[Intravenous iron in the treatment of postoperative anemia in surgery of the spine in infants and adolescents].
Topics: Administration, Oral; Adolescent; Adult; Anemia; Blood Loss, Surgical; Child; Child, Preschool; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Humans; Injections, Intravenous; Iron; Postoperative Complications; Spinal Fusion; Sucrose | 1998 |
Pharmacokinetics and red cell utilization of iron(III) hydroxide-sucrose complex in anaemic patients: a study using positron emission tomography.
Topics: Adult; Anemia; Erythrocytes; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Humans; Male; Middle Aged; Sucrose; Tomography, Emission-Computed; Transferrin | 1999 |
Aggressive therapy of congestive heart failure and associated chronic renal failure with medications and correction of anemia stops or slows the progression of both diseases.
Topics: Aged; Anemia; Disease Progression; Drug Therapy, Combination; Erythropoietin; Female; Ferric Compounds; Ferric Oxide, Saccharated; Glomerular Filtration Rate; Glucaric Acid; Heart Failure; Humans; Kidney Failure, Chronic; Male; Recombinant Proteins; Stroke Volume; Sucrose | 2001 |
Oral iron therapy with ferrous fumarate and polysaccharide iron complex.
Topics: Administration, Oral; Anemia; Contraindications; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Kidney Diseases; Renal Dialysis | 1992 |
Risk of iron overload and 'hemochromatosis allele(s)' in patients on maintenance hemodialysis.
Topics: Adolescent; Adult; Aged; Alleles; Anemia; Child; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Glucaric Acid; Hemochromatosis; Humans; Male; Renal Dialysis; Risk; Transfusion Reaction; Uremia | 1987 |